Clinical Trials Directory

Trials / Terminated

TerminatedNCT01408407

Alkagin Paste in the Prevention of Radiation Dermatitis

A Phase II Study Designed to Evaluate the Value of Alkagin Paste in the Prevention of Radiation Dermatitis for Patients Undergoing External Radiation Therapy

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Dr. Te Vuong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Alkagin paste is effective at preventing radiodermatitis in patients receiving external beam radiation therapy to the perineal area.

Conditions

Interventions

TypeNameDescription
OTHERAveeno creamApply cream on irradiated area twice a day
OTHERAlkagin pasteApply Alkagin paste three times a day.

Timeline

Start date
2011-12-01
Primary completion
2014-05-01
First posted
2011-08-03
Last updated
2015-05-25

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01408407. Inclusion in this directory is not an endorsement.

Alkagin Paste in the Prevention of Radiation Dermatitis (NCT01408407) · Clinical Trials Directory